HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paulo C Maciag Selected Research

vendex

1/2021Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paulo C Maciag Research Topics

Disease

4Multiple Myeloma
01/2021 - 11/2017
4Neoplasms (Cancer)
01/2013 - 02/2009
3Infections
12/2020 - 07/2002
2Breast Neoplasms (Breast Cancer)
05/2009 - 02/2009
2Neoplasm Metastasis (Metastasis)
05/2009 - 02/2009
1Pneumonia (Pneumonitis)
12/2020
1Thrombocytopenia (Thrombopenia)
12/2020
1Septic Shock (Toxic Shock Syndrome)
12/2020
1Neutropenia
12/2020
1Communicable Diseases (Infectious Diseases)
07/2010
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2009
1Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2008
1Papillomavirus Infections
07/2002

Drug/Important Bio-Agent (IBA)

3venetoclaxIBA
01/2021 - 11/2017
3AntigensIBA
01/2013 - 05/2006
3VaccinesIBA
07/2010 - 02/2009
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 12/2020
2Proteins (Proteins, Gene)FDA Link
11/2017 - 05/2009
2HLA Antigens (Human Leukocyte Antigens)IBA
08/2008 - 07/2002
1vendexIBA
01/2021
1Bortezomib (Velcade)FDA Link
12/2020
1Myeloid Cell Leukemia Sequence 1 ProteinIBA
11/2017
1Recombinant ProteinsIBA
01/2013
1Pathogen-Associated Molecular Pattern MoleculesIBA
01/2013
1Bacterial VaccinesIBA
07/2010
1Listeria monocytogenes hlyA protein (listeriolysin O)IBA
05/2009
1EpitopesIBA
05/2009
1Cancer VaccinesIBA
05/2009
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
05/2009
1HLA-A2 Antigen (HLA A2 Antigen)IBA
02/2009
1HLA-DRB1 Chains (HLA DRB1)IBA
07/2002

Therapy/Procedure

3Therapeutics
12/2020 - 05/2009
2Immunotherapy
01/2013 - 05/2009